In February 2026, Recursion Pharmaceuticals reported fourth-quarter 2025 revenue of US$35.54 million, sharply higher than a year earlier, while its quarterly net loss narrowed to US$108.12 million and ...
Recursion Pharmaceuticals Inc. (NASDAQ:RXRX) is one of the 11 most popular AI penny stocks to buy now. On February 25, Recursion Pharmaceuticals Inc. (NASDAQ:RXRX) reported Q4 revenue of $35.5 million ...
Artificial intelligence is rapidly inventing new drugs for diseases from Parkinson's disease and antibiotic-resistant superbugs to rare lung conditions.
Detailed price information for Recursion Pharmaceuticals Inc Cl A (RXRX-Q) from The Globe and Mail including charting and trades.
array(1) { [0]=> object(AdvItems)#303 (17) { ["image"]=> NULL ["delete_image"]=> NULL ["publish_start_int"]=> string(10) "1772305246" ["publish_end_int"]=> string(10 ...
Правительство Югры приняло ряд решений, касающихся газификации, реагирования на чрезвычайные ситуации и перехода на российские цифровые ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results